VATS Lobectomy: A Feasibility Study

Originating Group

CALGB 39802

P.I.: Dr. Scott Swanson

Participating Groups

Objectives

1. To determine the feasibility of performing VATS lobectomy in patients with small (<= 3cm.) peripheral non-small cell lung cancers, where feasibility is defined as the ability to carry out a lobectomy using a VATS approach without significant morbidity or peri-operative mortality.
2. To determine the rate at which a thoracotomy must be carried out to complete a VATS lobectomy.
3. To describe the complications associated with VATS lobectomy.
4. To describe the length of the operative procedure, the duration of chest tube stay, and length of hospitalization.
5. To describe the survival and failure-free survival, over a 5-year period, of patients with a small, peripheral non-small cell lung cancer who have had a VATS lobectomy.

Eligibility

1. Solitary peripheral (in the outer half of the lung field on radiograph), <=3cm. lung lesion.
2. Suspected or histologically documented non-small cell lung cancer (NSCLC)
3. No metastatic disease. If mediastinal lymph nodes are >1cm on pre-study chest CT, a mediastinoscopy (anterior, cervical or both) must be performed. If lymph nodes are positive at mediastinoscopy the patient is not eligible.
4. ECOG performance status 0-2.

Schema

Comments